Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of topiroxostat tablets in gout with hyperuricemia
CTR20262561Phase 3Active
- Sponsor
- 山东新华制药股份有限公司
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiroxostat in gout, hyperuricemia, sponsored by 山东新华制药股份有限公司. Started Jul 2026; status: active.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20262561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262561.